People treated with gene therapy cannot receive a second dose for fear of a dangerous immune response. Researchers hope to find a way around this. People treated with gene therapy cannot receive a second dose for fear of a dangerous immune response. Researchers hope to find a way around this.
SAN DIEGO, Feb. 29, 2024 /PRNewswire/ Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates ,.
Dillingham fifth-grader wins national art prize kdlg.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kdlg.org Daily Mail and Mail on Sunday newspapers.